Trial site
Boston University Medical Center
Boston, Massachusetts 02118, United StatesNot linked to an institution yet
- 12running trials
- 9closed trials
The trials here
What the 21 trials at this site are about, from their registry records.
- Phase
- Phase 37 trials
- Phase 24 trials
- Phase 42 trials
- Phase 11 trial
- Phase 1/21 trial
- Status
- Active, not recruiting8 trials
- Completed6 trials
- Recruiting3 trials
- Terminated3 trials
- Enrolling by invitation1 trial
- Lead sponsor
- Janssen Research & Development, LLC8 trials
- United Therapeutics2 trials
- Biogen1 trial
- Boston University1 trial
- CHDI Foundation, Inc.1 trial
- and 8 more
Running trials
Recruiting
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
NCT07258511· Phase 3· Janssen Research & Development, LLC· Source
Recruiting
Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated With Oral Anticoagulation
NCT05723926· Javelin Medical· Source
Contact: Thanh Nguyen, Dr
Recruiting
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
NCT06667076· Phase 2· Janssen Research & Development, LLC· Source
Active, not recruiting
Study of NXC-201 CAR-T in Patients With Light Chain (AL) Amyloidosis
NCT06097832· Phase 1/2· Nexcella Inc.· Source
Active, not recruiting
A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma
NCT05572515· Phase 3· Janssen Research & Development, LLC· Source
Active, not recruiting
A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment
NCT05455320· Phase 3· Janssen Research & Development, LLC· Source
Recruiting
Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier
NCT06426628· Veracyte, Inc.· Source
Contact: Ehab Billatos, MD
Active, not recruiting
A Study of Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) Amyloidosis
NCT05250973· Phase 2· Janssen Research & Development, LLC· Source
Active, not recruiting
Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to Daratumumab
NCT04270175· Phase 2· Weill Medical College of Cornell University· Source
Enrolling by invitation
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
NCT03683186· Phase 3· United Therapeutics· Source
Active, not recruiting
A Study of Lazertinib as Monotherapy or in Combination With Amivantamab in Participants With Advanced Non-small Cell Lung Cancer
NCT04077463· Phase 1· Janssen Research & Development, LLC· Source
Active, not recruiting
DECAMP-2: Screening of Patients With Early Stage Lung Cancer or at High Risk for Developing Lung Cancer
NCT02504697· Boston University· Source
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Closed trials
Completed
A Study to Learn About the Safety of BIIB122 Tablets and Whether They Can Slow the Worsening of Early-Stage Parkinson's Disease in Adults Between the Ages of 30 and 80
NCT05348785· Phase 2· Biogen· Source
Terminated
Oxbryta® Product Registry An Observational Study Designed to Evaluate the Effect of Oxbryta in Individuals With SCD
NCT04930445· Pfizer· Source
Recruiting
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
NCT04373564· Phase 4· Guerbet· Source
Contact: Nathalie LE FUR, PhD
Completed
A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients
NCT03626688· Phase 3· United Therapeutics· Source
Completed
A Study Comparing Daratumumab, VELCADE (Bortezomib), Lenalidomide, and Dexamethasone (D-VRd) With VELCADE, Lenalidomide, and Dexamethasone (VRd) in Participants With Untreated Multiple Myeloma and for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy
NCT03652064· Phase 3· Janssen Research & Development, LLC· Source
Completed
PRO-ACTIVE: Prophylactic Swallow Intervention for Patients Receiving Radiotherapy for Head and Neck Cancer
NCT03455608· University Health Network, Toronto· Source
Completed
A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis
NCT03201965· Phase 3· Janssen Research & Development, LLC· Source
Completed
Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement
NCT02810704· Phase 4· Dartmouth-Hitchcock Medical Center· Source
Recruiting
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
NCT01574053· CHDI Foundation, Inc.· Source
Contact: Noopur Modi
Report an error